Literature DB >> 31366490

Long Noncoding RNA, ANRIL, Regulates the Proliferation of Head and Neck Squamous Cell Carcinoma.

Natsumi Matsunaga1, Takahiro Wakasaki2, Ryuji Yasumatsu2, Yojiro Kotake3,4.   

Abstract

BACKGROUND/AIM: ANRIL is a long noncoding RNA located on INK4 locus, which encodes p15 and p16 that cause G1 phase arrest in the cell cycle. ANRIL positively regulates proliferation of several kinds of cancer cells such as lung and gastric cancers. This study, examined the effect of ANRIL in head and neck squamous cell carcinoma cells.
MATERIALS AND METHODS: Cells were transfected with siRNA oligonucleotides targeting ANRIL. Transfected cells were subjected to cell-cycle and quantitative reverse transcription-polymerase chain reaction (qRT-PCR) analysis.
RESULTS: Depletion of ANRIL increased p15 mRNA in FaDu cells, and p15 and p16 mRNA in CAL27 cells and inhibited proliferation of these cells. Cell cycle analysis showed that depletion of ANRIL caused arrest at the G1 phase of the cell cycle.
CONCLUSION: ANRIL promotes G1 phase progression by repressing p15 and p16, and thus promotes FaDu and CAL27 cell proliferation. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  ANRIL; CDK inhibitor; cell cycle; head and neck squamous cell carcinoma

Mesh:

Substances:

Year:  2019        PMID: 31366490     DOI: 10.21873/anticanres.13564

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Long Noncoding RNA ANROC on the INK4 Locus Functions to Suppress Cell Proliferation.

Authors:  Yojiro Kotake; Takeshi Tsuruda
Journal:  Cancer Genomics Proteomics       Date:  2020 Jul-Aug       Impact factor: 4.069

2.  Comparison of Conventional Fractionation and Accelerated Fractionation With Concomitant Boost for Radiotherapy of Non-metastatic Stage IV Head-and-Neck Cancer.

Authors:  Carlos Narvaez; Steven E Schild; Dirk Rades
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.406

3.  LINC00703 Acts as a Tumor Suppressor via Regulating miR-181a/KLF6 Axis in Gastric Cancer.

Authors:  Haiyang Yang; Minqi Peng; Yanjiao Li; Renjie Zhu; Xiang Li; Zhengjiang Qian
Journal:  J Gastric Cancer       Date:  2019-12-16       Impact factor: 3.720

4.  Upregulating the Expression of LncRNA ANRIL Promotes Osteogenesis via the miR-7-5p/IGF-1R Axis in the Inflamed Periodontal Ligament Stem Cells.

Authors:  Minxia Bian; Yan Yu; Yuzhi Li; Zhou Zhou; Xiao Wu; Xiaying Ye; Jinhua Yu
Journal:  Front Cell Dev Biol       Date:  2021-02-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.